Search
for
Sort by
Research 31–60 of 1000+
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study
- Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study
- Health-related quality of life questionnaire for polycystic ovary syndrome (PCOSQ-50): development and psychometric properties
- Finasteride treatment for one year in 35 hirsute patients
- Progesterone Inhibits the Growth of Human Neuroblastoma: In Vitro and In Vivo Evidence
- Dupilumab side effect in a patient with atopic dermatitis: a case report study
- Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome
- Relationships Between Biochemical Markers of Hyperandrogenism and Metabolic Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
- Is acne a sign of androgen excess disorder or not?
- The Polycystic Ovary Syndrome Health-Related Quality-of-Life Questionnaire: Confirmatory Factor Analysis
- A comparison between finasteride, flutamide, and finasteride plus flutamide combination in the treatment of hirsutism
- Low-dose (2.5 mg/day) finasteride treatment in hirsutism
- Female Gender Scheme is Disturbed by Polycystic Ovary Syndrome: A Qualitative Study From Iran
- International PCOS guideline clinical research priorities roadmap: a co-designed approach aligned with end-user priorities in a neglected women’s health condition
- The Effect of Platelet Rich Plasma on Hair Re‐growth in Patients with Alopecia Areata Totalis: a Clinical Pilot Study
- Efficacy of platelet-rich plasma in androgenetic alopecia patients
- An Asian traditional herbal complex containing Houttuynia cordata Thunb, Perilla frutescens Var. acuta and green tea stimulates hair growth in mice
- Dermatopathia Pigmentosa Reticularis: Report of a New Cases and Literature Review
- Development and ex-vivo skin permeation studies of finasteride–poly(lactic acid-<i>co</i>-glycolic acid) and minoxidil–chitosan nanoparticulate systems
- An epidemiological study of 97 cases of primary cicatricial alopecia in Iran
- Medical treatment regimens of hirsutism
- Comparison of spironolactone and spironolactone plus finasteride in the treatment of hirsutism
- Idiopathic hirsutism: Is it really idiopathic or is it misnomer?
- Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome
- The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study
- Androgenetic alopecia and COVID ‐19: A review of the hypothetical role of androgens
- Hirsutism – From Diagnosis to Use of Antiandrogens
- Age-specific cut-off levels of anti-Müllerian hormone can be used as diagnostic markers for polycystic ovary syndrome
- Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome